· Liver failure
· Absorption
· Distribution
· Metabolism
· Excretion
· Dynamics
Definition |
Failure of the liver to perform its functions: · Metabolise energy substrates, drugs, toxins · Synthesise albumin, α1 acid glycoprotein (AAG), coag proteins, bile · Store energy substrates, metals |
Associated features |
· Portal hypertension · Portosystemic shunt |
Oral |
↓First pass metabolism + ↑Portosystemic shunt · ↑Bioavailability · ↑Toxicity (e.g. lignocaine airway topicalization) ↓Bile secretion · ↓Absorption of Vitamins A, D, E, K |
Rectal |
Same factors -> improved rectal bioavailability |
↑ECF volume |
↑VD hydrophilic drugs -> ↑loading dose required (e.g. rocuronium) |
↓Albumin ↓α1 acid glycoprotein |
↑Unbound drug · If highly bound and poorly metabolized -> ↑risk toxicity · e.g. phenytoin -> arrhythmia |
|
Hepatic extraction ratio (HER) = [drug] in hepatic artery – [drug] in hepatic vein / [drug] in hepatic artery |
↓Phase 1&2 reaction |
↓Clearance if metabolism-limited drugs (HER <0.3) · e.g. thiopentone -> prolonged hypnosis · Phase 1 affected before phase 2 |
↓Hepatic blood flow (if cirrhosis) |
↓Clearance if flow-limited (HER >0.7) · e.g. lignocaine -> seizure, arrhythmia, arrest |
↓Plasma cholinesterase production |
↓Clearance of suxamethonium, mivacurium, ester local anaesthetics |
Bile |
↓Production · ↓Excretion of large and/or lipophilic drugs and metabolites -> ↑toxicity · e.g. vecuronium -> prolonged paralysis |
Urine |
Hepatorenal syndrome · ↓Excretion of small and/or hydrophilic drugs and metabolites -> ↑toxicity · E.g. morphine-3-glucuronide -> seizure |
Brain |
Altered CNS receptor response · ↑Sensitivity to opioids, benzodiazepines Hyperammonaemia -> hepatic encephalopathy |
Blood |
↓Clotting factors, ↓anticoagulant factors, platelet sequestration · Unpredictable clotting status · Unpredictable effect of anticoagulants |
Kidney |
↑Sensitivity to nephrotoxins (e.g. gentamicin) -> hepatorenal syndrome |
Liver |
↑Sensitivity to hepatotoxins (e.g. paracetamol) -> worsening failure |
Feedback welcome at ketaminenightmares@gmail.com